Skadden, Arps, Slate, Meagher & Flom LLP is known for its debtor-side work representing large public companies in complex in-court and out-of-court restructurings and liability management transactions. New York-based Paul Leake leads the team and advises companies, boards, creditors and investors across Chapter 11 reorganisations, out-of-court restructurings and DIP financings. Shana Elberg in New York advises multinational companies in high-profile Chapter 11 cases and out-of-court workouts. Ron Meisler in Chicago advises on Chapter 11 cases, distressed acquisitions and out-of-court transactions including contested Section 363 sale proceedings. James Mazza in Chicago advises debtors, boards and investors across Chapter 11 restructurings, liability management transactions and DIP financings.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Client satisfaction: Billing & efficiency
Client satisfaction: Sector knowledge
Key clients
- TTAM Research Institute
- Endo International plc. and its debtor affiliates
- New Fortress Energy Inc.
- True Value Company LLC
- National Hockey League
- Funds affiliated with Castlelake, L.P.
- LL Flooring Holdings, Inc.
- DZ 21st Street LLC
- Lucid Group, Inc.
- Del Monte Pacific Limited
- E-House (China) Enterprise Holdings Limited
- Clear Blue Specialty Insurance Company
Work highlights
Represented TTAM Research Institute, a nonprofit public benefit corporation based in California and led by 23andMe co-founder and former CEO Anne Wojcicki, in its $305 million purchase of 23andMe Holding Co. under Section 363 of the Bankruptcy Code.
Represented Endo International, a multi-national generics and specialty branded pharmaceutical company (“Company”), as lead counsel to the Company and its affiliates in their Chapter 11 cases in the U.S. Bankruptcy Court for the Southern District of New York.
Advising New Fortress Energy Inc. on two transformative debt and equity transactions totalling approximately $3 billion. On October 2, 2024, the company issued more than 46 million shares of its Class A common stock at a public offering price of $8.63 per share, totalling $400 million.
Practice head
Paul Leake
Other key lawyers
Shana Elberg; Ron Meisler; James Mazza